HK1038886B - USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF KIDNEY DISORDER - Google Patents
USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF KIDNEY DISORDERInfo
- Publication number
- HK1038886B HK1038886B HK02100508.3A HK02100508A HK1038886B HK 1038886 B HK1038886 B HK 1038886B HK 02100508 A HK02100508 A HK 02100508A HK 1038886 B HK1038886 B HK 1038886B
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitors
- tgf
- preparation
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/18—Materials not provided for elsewhere for application to surfaces to minimize adherence of ice, mist or water thereto; Thawing or antifreeze materials for application to surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Combustion & Propulsion (AREA)
- Materials Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8658798P | 1998-05-22 | 1998-05-22 | |
US8876698A | 1998-06-02 | 1998-06-02 | |
US15048598A | 1998-09-09 | 1998-09-09 | |
PCT/US1999/011073 WO1999061040A2 (en) | 1998-05-22 | 1999-05-19 | USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1038886A1 HK1038886A1 (en) | 2002-04-04 |
HK1038886B true HK1038886B (en) | 2005-09-23 |
Family
ID=27375439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02100508.3A HK1038886B (en) | 1998-05-22 | 2002-01-22 | USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF KIDNEY DISORDER |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100574597B1 (en) |
HK (1) | HK1038886B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA116639C2 (en) * | 2012-10-09 | 2018-04-25 | Рег'Юлес Терап'Ютікс Інк. | Methods for treatment of alport syndrome |
-
1999
- 1999-05-19 KR KR1020007013144A patent/KR100574597B1/en not_active IP Right Cessation
-
2002
- 2002-01-22 HK HK02100508.3A patent/HK1038886B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010052390A (en) | 2001-06-25 |
KR100574597B1 (en) | 2006-04-28 |
HK1038886A1 (en) | 2002-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076723A1 (en) | Highly selective norepinephrine reuptake inhibitors and the use for the preparation of the medicament thereof | |
HUP0200831A2 (en) | Novel pharmaceutical composition containing amoxycillin and its use | |
NZ513889A (en) | Kappa agonist compounds, pharmaceutical formulations and methods of prevention and treatment of pruritus therewith | |
HUP0202319A3 (en) | Use of mek inhibitors for the preparation of pharmaceutical compositions treating chronic pain | |
HUP0400529A3 (en) | Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders | |
HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
HUP0004120A3 (en) | Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy | |
ZA985618B (en) | Sulfonamide compounds and pharmaceutical use thereof | |
HUP0302044A3 (en) | Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity | |
HUP0202814A3 (en) | Androgen receptor modulator compounds and methods for their preparation and pharmaceutical compositions containing them and their use | |
EP0858334A4 (en) | Analgesic immediate and controlled release pharmaceutical composition | |
HUP0103558A3 (en) | Pharmaceutical composition containing nmda receptor antagonist for the treatment of stroke and traumatic brain insury | |
HK1015351A1 (en) | Substituted amino compounds and their use as analgesic active substances | |
IL138888A0 (en) | Pharmaceutical composition and combination preparation for immunosuppressive therapy | |
IL138416A (en) | Use of dexmedetomidine or pharmaceutical acceptable salt thereof for preparation of a sedative | |
HUP0202048A2 (en) | Use of alpha1betha1 integrin receptor inhibitors and tgf-betha1 inhibitors in the treatment of kidney disease | |
HUP0100171A3 (en) | Use of endothelin receptor antagonists for producing pharmaceutical preparations for combating obesity | |
HK1038886B (en) | USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF KIDNEY DISORDER | |
HUP9802716A3 (en) | Pharmaceutical composition of analgesic activity | |
EE200900049A (en) | Ethin 1 "Pharmaceutical Composition Containing Stradiol and Drospirenone for Use as a Contraceptive | |
AU2001291994A1 (en) | Dipeptide ligands of the npff receptor for treating pain and hyperalgesia | |
HUP0201629A3 (en) | Pharmaceutical complex containing eletriptan and cyclodextrin-derivative, pharmaceutical composition containing it, process for its preparation and its use | |
EP1243609A4 (en) | Succinimide compounds and use thereof | |
HUP0103947A3 (en) | Novel methanesulfonate salts of pyridopyrazine compound and crystals thereof and their pharmaceutical use | |
ZA98484B (en) | Use of beta3-adrenergic receptor agonists for the preparation of healing drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090519 |